Teleton has 24 Medical Centers (22 rehabilitation centers, 1
autism center and 1 Children's Hospital for Cancer)
located across the country, and around 600,000 patients with
disability, cancer and autism conditions
The partnership includes:
- Establishment of Khiron's Zerenia™ medical cannabis clinics
within Teleton's network across Mexico
- Distribution of Khiron's medical cannabis products in Teleton's
pharmacies
- Training of Teleton's Health Care Practitioners on delivery of
medical cannabis
TORONTO, March 30,
2022 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or
the "Company") (TSXV: KHRN) (OTCQX: KHRNF) (Frankfurt: A2JMZC), the global medical
cannabis leader expanding throughout Latin America and Europe, has partnered with health care company
Teleton to bring access to medical cannabis to more than 24 medical
centers across Mexico.
Khiron is a leader in the marketplace with its end-to-end
solution focusing on the category of medical cannabis. Khiron has a
proprietary, sustainable model of growing, distributing, and
prescribing cannabis for a range of health care solutions in its
Zerenia ™ medical cannabis clinics. Leveraging their wholly-owned
medical clinics and proprietary telemedicine platforms, Khiron
combines a patient-oriented approach, physician education programs,
scientific expertise, product innovation, and to drive
prescriptions and brand loyalty with patients worldwide.
"The establishment of Khiron's Zerenia™ medical cannabis clinics
in Teleton's medical centers is only the beginning of our
go-to-market strategy and medical partnerships in Mexico," says Alvaro
Torres, Khiron CEO and Director. "We are focused on
delivering the highest quality and best care to patients and
ongoing education to doctors and communities at large."
Khiron has also obtained regulatory quotas (authorization to use
a control substance under International Conventions) from
Mexico's regulatory agency
COFEPRIS for importing CBD and THC into the country and is
currently securing permits for imports to begin commercial sales in
the country. With Mexico's population of nearly 130 million,
it is among the top 15 economies worldwide, Khiron's serves more
than 11.7 million people who have conditions treatable with medical
cannabis.
Arturo Pichardo, Corporate
Medical Director of Teleton, adds, "Teleton and Khiron's Zerenia™
clinic network complement each other perfectly with our strong
patient focus, as we share the same values about our common
mission. This partnership is good news for patients with various
medical conditions throughout Mexico."
Khiron has also partnered with Mexico's top university Tecnologico de
Monterrey to provide medical
cannabis training to doctors across the country, based on Khiron's
education programs and real-world evidence from its Zerenia™
clinics across Latin America.
About Teleton
Fundación Teletón is a non-profit
organization that seeks to serve children with disabilities, cancer
and autism, offering them comprehensive and quality care that
promotes their full development and inclusion in society. In
Mexico, it has 22 Rehabilitation
Centers, 1 Autism Center and 1 Children´s Hospital for Cancer,
located across the country, and around 600,000 patients with
disability, cancer and autism conditions attending since 1.999. It
is part of ORITEL (The International Organization of Telethons),
the integrating entity of 12 American countries (including
the United States) that nowadays
form part of the Telethon Organization which was created with the
objective of providing and developing services of habilitation,
rehabilitation and inclusion of children and adolescents with
disabilities.
About Khiron Life Sciences Corp.
Khiron is a leading
global medical cannabis company with core operations in
Latin America and Europe. Leveraging wholly-owned medical health
clinics and proprietary telemedicine platforms, Khiron combines a
patient-oriented approach, physician education programs, scientific
expertise, product innovation, and focus on creating access to
drive prescriptions and brand loyalty with patients worldwide. The
Company has a sales presence in Colombia, Germany, UK, Peru, and Brazil and is positioned to commence sales in
Mexico. The Company is led by
Co-founder and Chief Executive Officer, Alvaro Torres, together with an experienced and
diverse executive team and Board of Directors.
Visit Khiron online at investors.khiron.ca
Linkedin https://www.linkedin.com/company/khiron-life-sciences-corp/
Cautionary Notes
Forward-Looking Statements
This press release may contain certain "forward-looking
information" and "forward-looking statements" within the meaning of
applicable securities legislation. All information contained herein
that is not historical in nature may constitute forward-looking
information. Khiron undertakes no obligation to comment on
analyses, expectations or statements made by third-parties in
respect of Khiron, its securities, or financial or operating
results (as applicable). Although Khiron believes that the
expectations reflected in forward-looking statements in this press
release are reasonable, such forward-looking statement has been
based on expectations, factors and assumptions concerning future
events which may prove to be inaccurate and are subject to numerous
risks and uncertainties, certain of which are beyond Khiron's
control, including the risk factors discussed in Khiron's Annual
Information Form which is available on Khiron's SEDAR profile at
www.sedar.com. The forward-looking information contained in this
press release is expressly qualified by this cautionary statement
and is made as of the date hereof. Khiron disclaims any intention
and has no obligation or responsibility, except as required by law,
to update or revise any forward-looking information, whether as a
result of new information, future events or otherwise.
Neither the TSXV nor its Regulation Services Provider (as that
term is defined in the policies of the TSXV) accepts responsibility
for the adequacy or accuracy of this press release.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/medical-cannabis-innovator-khiron-continues-to-disrupt-global-marketplace-signing-partnership-with-teleton-in-mexico-301513662.html
SOURCE Khiron Life Sciences Corp.